Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Amifostine for Injection

Approval Number

国药准字H20249418

Company四川汇宇海玥医药科技有限公司

Registration Date

November 22, 2024

Drug Information

Generic Name

注射用氨磷汀

Dosage Form

注射剂

Strength

0.5g（按C₅H₁₅N₂O₃PS计）

Drug Type

化学药品

Registration Date

November 22, 2024

Company Information

Applicant Company

Company Name四川汇宇海玥医药科技有限公司

Company Address

成都天府国际生物城（双流区岐黄二路1533号）

Manufacturing Company

Company Name四川汇宇制药股份有限公司

Company Address

四川省内江市市中区汉阳路333号3幢

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy